查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1543875

血管成形術用氣球的全球市場

Angioplasty Balloons
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球血管成形術用氣球市場預計將達到 38 億美元

2023年全球血管成形術用氣球市場估計為29億美元，預計2030年將達到38億美元，2023-2030年分析期間複合年成長率為3.9%。普通氣球是本報告分析的細分市場之一，預計複合年成長率為 3.9%，到分析期結束時將達到 21 億美元。在分析期間，藥物塗層球囊市場預計將以 4.1% 的複合年成長率成長。

美國市場預估達7.682億美元，中國預計複合年成長率為5.9%

預計 2023 年美國血管成形術用氣球市場規模將達 7.682 億美元。中國作為全球第二大經濟體，預計2030年市場規模將達到7.876億美元，2023年至2030年複合年成長率為5.9%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 2.6% 和 3.0%。在歐洲，德國的複合年成長率預計為 3.0%。

全球血管成形術用氣球市場－主要趨勢與促進因素總結

血管成形術用氣球如何徹底改變心臟照護？

血管成形術用氣球是介入性心臟病學領域的重要工具，在冠狀動脈疾病（CAD）的治療中發揮至關重要的作用。這些裝置用於經皮冠狀動脈介入治療（PCI），以擴寬狹窄或阻塞的冠狀動脈，恢復心肌的血流，並緩解胸痛和呼吸短促等症狀。在此過程中，將末端帶有放氣球的導管插入受影響的動脈中。一旦就位，氣球就會膨脹，將斑塊推向動脈壁並擴張血管。血管成形術用氣球的引入徹底改變了心臟護理，為冠狀動脈繞道手術移植術 (CABG) 提供了微創替代方案，減少了患者的康復時間和住院時間。

哪些技術創新提高了血管成形術用氣球的有效性？

技術的進步大大提高了血管成形術用氣球的有效性和安全性。藥物釋放型球囊 (DEB) 的開發透過將機械斑塊壓縮與局部藥物輸送相結合，代表了預防血管再阻塞或動脈血管再阻塞的重大創新。這些球囊塗有抗增生藥物，當膨脹時，這些藥物會釋放到動脈壁中，以抑制導致血管再阻塞的疤痕組織的生長。此外，球囊導管的引入透過對斑塊進行受控切割，改善了我們處理特別頑固或鈣化病變的方式。這些進步不僅提高了血管成形術的成功率，而且減少了再次手術的需要並改善了患者的長期預後。

為什麼以病人為中心的照護對於血管成形術用氣球的引入至關重要？

以患者為中心的照護是採用血管成形球囊手術並取得成功的重要因素。隨著對個人化醫療的重視，醫療保健提供者越來越注重根據患者的個別需求和狀況量身定做治療方案。這種方法需要仔細評估患者的特定因素，包括動脈閉塞的嚴重程度和位置、一般健康狀況和併發症。增強的影像技術和診斷工具可以準確規劃和執行血管成形術，確保最佳的球囊選擇和放置。此外，病患教育和術後護理在改善治療結果方面發揮著重要作用。因為知情的患者更有可能遵循保持動脈健康所必需的處方藥物和生活方式改變。在心臟護理中轉向以患者為中心的整體方法不僅可以改善臨床結果，還可以提高患者滿意度和生活品質。

血管成形術用氣球市場成長的因素有哪些？

血管成形術用氣球市場的成長是由與技術進步、最終用途和不斷發展的醫療保健實踐相關的幾個因素所推動的。由於人口老化和生活方式相關危險因素，全球冠心病負擔持續增加，心血管疾病（特別是冠狀動脈疾病）盛行率不斷上升，已成為主要促進因素。藥物釋放型球囊和切割/球囊導管等創新透過提高手術效率和患者治療效果來推動市場成長。在基於導管的技術和診斷成像的進步的支持下，向微創治療的轉變正在擴大血管成形術用氣球在不同患者群體中的使用。此外，隨著對預防性護理和早期診斷的日益重視，血管成形術經常作為 CAD 的第一線治療方法。新興市場不斷擴大的醫療基礎設施和不斷上漲的醫療成本也促進了市場成長，增加了先進心臟治療技術的取得機會。此外，對個人化醫療和以患者為中心的護理模式的關注正在推動對客製化血管成形術解決方案的需求，進一步加速市場擴張。

受訪企業範例（44家知名企業）

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • BARD, A Becton, Dickinson Company
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Cook Medical LLC
  • Endocor GmbH
  • Medtronic PLC
  • Terumo Corporation
  • The Spectranetics Corporation

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 比賽

簡介目錄
Product Code: MCP10289

Global Angioplasty Balloons Market to Reach US$3.8 Billion by 2030

The global market for Angioplasty Balloons estimated at US$2.9 Billion in the year 2023, is expected to reach US$3.8 Billion by 2030, growing at a CAGR of 3.9% over the analysis period 2023-2030. Normal Balloons, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$2.1 Billion by the end of the analysis period. Growth in the Drug-Coated Balloons segment is estimated at 4.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$768.2 Million While China is Forecast to Grow at 5.9% CAGR

The Angioplasty Balloons market in the U.S. is estimated at US$768.2 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$787.6 Million by the year 2030 trailing a CAGR of 5.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.6% and 3.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.0% CAGR.

Global Angioplasty Balloons Market - Key Trends and Drivers Summarized

How Are Angioplasty Balloons Revolutionizing Cardiac Care?

Angioplasty balloons are integral tools in the field of interventional cardiology, playing a pivotal role in the treatment of coronary artery disease (CAD). These devices are used in percutaneous coronary interventions (PCI) to dilate narrowed or blocked coronary arteries, restoring blood flow to the heart muscle and alleviating symptoms such as chest pain and shortness of breath. The procedure involves inserting a catheter with a deflated balloon at its tip into the affected artery. Once positioned, the balloon is inflated to compress the plaque against the artery walls, thereby widening the vessel. The advent of angioplasty balloons has revolutionized cardiac care by offering a minimally invasive alternative to coronary artery bypass grafting (CABG), reducing recovery times and hospital stays for patients.

What Technological Innovations Are Enhancing the Efficacy of Angioplasty Balloons?

Technological advancements have significantly enhanced the efficacy and safety of angioplasty balloons. The development of drug-eluting balloons (DEBs) represents a major innovation, combining mechanical plaque compression with localized drug delivery to prevent restenosis, or re-narrowing of the artery. These balloons are coated with antiproliferative drugs, which are released into the arterial wall during inflation, inhibiting the growth of scar tissue that can lead to restenosis. Additionally, the introduction of cutting and scoring balloons, equipped with tiny blades or scoring elements, provides an improved method for tackling particularly tough or calcified lesions by creating controlled incisions in the plaque. These advancements not only improve the success rates of angioplasty procedures but also reduce the need for repeat interventions, enhancing long-term patient outcomes.

Why Is Patient-Centric Care Vital in the Adoption of Angioplasty Balloons?

Patient-centric care is a critical factor in the adoption and success of angioplasty balloon procedures. With a growing emphasis on personalized medicine, healthcare providers are increasingly focusing on tailoring treatments to individual patient needs and conditions. This approach involves careful assessment of patient-specific factors such as the severity and location of arterial blockages, overall health, and coexisting medical conditions. Enhanced imaging techniques and diagnostic tools enable precise planning and execution of angioplasty procedures, ensuring optimal balloon selection and placement. Moreover, patient education and post-procedural care play a vital role in improving outcomes, as informed patients are more likely to adhere to prescribed medications and lifestyle modifications necessary to maintain artery health. The shift towards a holistic, patient-centric approach in cardiac care not only improves clinical outcomes but also enhances patient satisfaction and quality of life.

What Factors Are Driving Growth in the Angioplasty Balloons Market?

The growth in the angioplasty balloons market is driven by several factors related to technological advancements, end-use applications, and evolving healthcare practices. The increasing prevalence of cardiovascular diseases, particularly coronary artery disease, is a major driver, as the global burden of CAD continues to rise with aging populations and lifestyle-related risk factors. Technological innovations, such as drug-eluting balloons and cutting/scoring balloons, are propelling market growth by improving procedural efficacy and patient outcomes. The shift towards minimally invasive procedures, supported by advancements in catheter-based technologies and imaging modalities, is expanding the use of angioplasty balloons in diverse patient populations. Additionally, the growing emphasis on preventive healthcare and early diagnosis is leading to more frequent use of angioplasty as a first-line treatment for CAD. The expansion of healthcare infrastructure in emerging markets and increased healthcare expenditure are also contributing to market growth, providing greater access to advanced cardiac care technologies. Moreover, the focus on personalized medicine and patient-centric care models is driving demand for tailored angioplasty solutions, further accelerating market expansion.

Select Competitors (Total 44 Featured) -

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • BARD, A Becton, Dickinson Company
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Cook Medical LLC
  • Endocor GmbH
  • Medtronic PLC
  • Terumo Corporation
  • The Spectranetics Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Angioplasty Balloons - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Prevalence of Cardiovascular Diseases Throws the Spotlight on Angioplasty Balloons
    • Technological Innovations in Drug-Eluting Balloons Propel Growth in the Market
    • Advances in Cutting and Scoring Balloons Expand Addressable Market Opportunity
    • Aging Population and Lifestyle-Related Risk Factors Drive Demand for Angioplasty Solutions
    • Minimally Invasive Procedures Trend Strengthens Business Case for Angioplasty Balloons
    • Integration of Advanced Imaging Techniques Generates Demand for Precision Angioplasty
    • Development of Portable and User-Friendly Devices Propels Adoption in Diverse Settings
    • Focus on Reducing Restenosis Rates Strengthens Business Case for Advanced Balloons
    • Integration of Digital Health and Remote Monitoring Generates New Market Opportunities
    • Trends in Outpatient Cardiac Care Propel Demand for Efficient Angioplasty Solutions
    • Investment in Innovative Catheter-Based Technologies Expands Addressable Market
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Angioplasty Balloons by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Angioplasty Balloons by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Angioplasty Balloons by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Angioplasty Balloons Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Normal Balloons by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Normal Balloons by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Normal Balloons by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Drug-Coated Balloons by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Drug-Coated Balloons by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Drug-Coated Balloons by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Coronary Angioplasty by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Coronary Angioplasty by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Coronary Angioplasty by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Peripheral Angioplasty by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Peripheral Angioplasty by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Peripheral Angioplasty by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Angioplasty Balloons Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2014, 2024 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2014, 2024 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2014, 2024 & 2030
  • JAPAN
    • Angioplasty Balloons Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2014, 2024 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2014, 2024 & 2030
  • CHINA
    • Angioplasty Balloons Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: China 16-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2014, 2024 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: China 16-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: China 16-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2014, 2024 & 2030
  • EUROPE
    • Angioplasty Balloons Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Angioplasty Balloons by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Angioplasty Balloons by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Angioplasty Balloons by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2014, 2024 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2014, 2024 & 2030
  • FRANCE
    • Angioplasty Balloons Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 77: France Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: France 16-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2014, 2024 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: France 16-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: France 16-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2014, 2024 & 2030
  • GERMANY
    • Angioplasty Balloons Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Germany 16-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2014, 2024 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Germany 16-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Germany 16-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Italy 16-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2014, 2024 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Italy 16-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Italy 16-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Angioplasty Balloons Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 104: UK Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: UK 16-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2014, 2024 & 2030
    • TABLE 107: UK Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: UK 16-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: UK 16-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 113: Spain Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Spain Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Spain 16-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2014, 2024 & 2030
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: Spain 16-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: Spain 16-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 122: Russia Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Russia Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Russia 16-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2014, 2024 & 2030
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Russia 16-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Russia 16-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of Europe 16-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2014, 2024 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of Europe 16-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of Europe 16-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Angioplasty Balloons Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Angioplasty Balloons by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Angioplasty Balloons by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Asia-Pacific 16-Year Perspective for Angioplasty Balloons by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Asia-Pacific 16-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2014, 2024 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Asia-Pacific 16-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Asia-Pacific 16-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Angioplasty Balloons Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 152: Australia Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Australia Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Australia 16-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2014, 2024 & 2030
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Australia 16-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Australia 16-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2014, 2024 & 2030
  • INDIA
    • Angioplasty Balloons Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 161: India Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: India Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: India 16-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2014, 2024 & 2030
    • TABLE 164: India Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: India 16-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 167: India Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: India 16-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 170: South Korea Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: South Korea Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: South Korea 16-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2014, 2024 & 2030
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: South Korea 16-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: South Korea 16-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Rest of Asia-Pacific Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Rest of Asia-Pacific 16-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2014, 2024 & 2030
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 16-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Angioplasty Balloons Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 188: Latin America Recent Past, Current & Future Analysis for Angioplasty Balloons by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 189: Latin America Historic Review for Angioplasty Balloons by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Latin America 16-Year Perspective for Angioplasty Balloons by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: Latin America 16-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2014, 2024 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Latin America 16-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Latin America 16-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 200: Argentina Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Argentina Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Argentina 16-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2014, 2024 & 2030
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Argentina 16-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Argentina 16-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 209: Brazil Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Brazil Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 211: Brazil 16-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2014, 2024 & 2030
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 214: Brazil 16-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 217: Brazil 16-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 218: Mexico Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 219: Mexico Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 220: Mexico 16-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2014, 2024 & 2030
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 223: Mexico 16-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 226: Mexico 16-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 228: Rest of Latin America Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 229: Rest of Latin America 16-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2014, 2024 & 2030
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 232: Rest of Latin America 16-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 235: Rest of Latin America 16-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Angioplasty Balloons Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 236: Middle East Recent Past, Current & Future Analysis for Angioplasty Balloons by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 237: Middle East Historic Review for Angioplasty Balloons by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 238: Middle East 16-Year Perspective for Angioplasty Balloons by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 241: Middle East 16-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2014, 2024 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 244: Middle East 16-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 247: Middle East 16-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 248: Iran Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 249: Iran Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 250: Iran 16-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2014, 2024 & 2030
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 253: Iran 16-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 256: Iran 16-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 257: Israel Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 258: Israel Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 259: Israel 16-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2014, 2024 & 2030
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 262: Israel 16-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 265: Israel 16-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 267: Saudi Arabia Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 268: Saudi Arabia 16-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2014, 2024 & 2030
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 271: Saudi Arabia 16-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 274: Saudi Arabia 16-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 275: UAE Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 276: UAE Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 277: UAE 16-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2014, 2024 & 2030
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 280: UAE 16-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 283: UAE 16-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 285: Rest of Middle East Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 286: Rest of Middle East 16-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2014, 2024 & 2030
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 289: Rest of Middle East 16-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 292: Rest of Middle East 16-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2014, 2024 & 2030
  • AFRICA
    • Angioplasty Balloons Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 293: Africa Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 294: Africa Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 295: Africa 16-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2014, 2024 & 2030
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 298: Africa 16-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 301: Africa 16-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2014, 2024 & 2030

IV. COMPETITION